baber/WOPTO huggingface dataset:
Patent JP-3771587-B2 (JP)
IPC: E02B7/02
Filed: 1996-02-29
Granted: 2006-04-26
Abstract: PCT No. PCT/SE96/00258 Sec. 371 Date Sep. 2, 1997 Sec. 102(e) Date Sep. 2, 1997 PCT Filed Feb. 29, 1996 PCT Pub. No. WO96/27710 PCT Pub. Date Sep. 12, 1996A liquid-damming protective bank comprises a member abutting against a surface upon which a vertical force acts with the purpose of pressing and anchoring the same against the surface. The bank member has a first long side edge turned towards a flood side and an opposite long side edge turned towards a dry side of the protective bank. Between the surface (2) and the bank member (1) there is applied a device (12) extending axially along the bank, e.g. a mat, the purpose of which is to drain away flood liquid possibly leaking in under the member from the flood side so as to keep the area on the bottom side of the member elongating from the long side edge of the draining device (12) being closest to the flood side to the dry side, at or close to atmospheric pressure in order to obtain a maximum pressure difference in relation to the hydraulic pressure keeping the protective bank sealing against the surface.
Patent ES-2276639-B2 (ES)
Title: Camara de erogacion para bebidas calientes.
Inventor: GUINDULAIN BUSTO FELIX
IPC: A47J31/40
Filed: 2006-12-29
Granted: 2008-04-16
Abstract: Cámara de erogación para bebidas calientes, de utilidad para su incorporación en las conocidas máquinas automáticas expendedoras de bebidas calientes, y en especial para la preparación de café, comprendiendo: un grupo de erogación que monta una cámara de depósito de la dosis de café molido; un grupo compresor de la dosis de café molido con el grupo de erogación en la fase de preparación del café; una boca de entrada del agua a presión, y; una boca de salida del café preparado, de forma que el grupo (5) compresor que comprime y define la cámara de erogación (6) en combinación con la cámara (3) de depósito de la dosis de café molido, incorpora un eje (7) central, a modo de válvula, solicitado por un resorte (8) tarado a una determinada presión que, en la fase de preparación del café, cierra la boca (9) de salida del café preparado en la cámara de erogación (6).
Patent ES-2385443-B2 (ES)
Title: Uso de compuestos derivados de urea pirimidínica para la elaboracion de un medicamento útil para el tratamiento de enfermedades inflamatorias.
Inventor: VILLAR HERNANDEZ JESUS
IPC: A61K31/505
Filed: 2010-12-28
Granted: 2013-05-16
Abstract: La presente invención es un compuesto derivado de urea pirimidínica para el tratamiento de enfermedades inflamatorias. El compuesto de la invención es útil para la preparación de una composición farmacéutica para el tratamiento de dichas enfermedades inflamatorias, preferiblemente, sepsis causada por bacterias Gram-negativas, artritis, infecciones renales, enfermedades pulmonares agudas inducidas por sepsis, síndrome de distrés respiratorio agudo inducido por sepsis, shock endotóxico o endotoxemia, peritonitis séptica, hepatitis aguda, disfunción miocárdica aguda inducida por shock séptico y enterecolitis necrotizante.
Patent ES-2353299-B2 (ES)
Title: Producto cerámico que comprende al menos un material de cambio de fase.
Inventor: CABRERA AHIS CARLOS
IPC: C04B35/00
Filed: 2011-01-14
Granted: 2011-09-16
Abstract: Producto cerámico que comprende al menos un
material de cambio de fase. 
     La presente invención se refiere a un producto
cerámico obtenible a partir de un procedimiento que comprende la
incorporación de al menos un material de cambio de fase en un
material cerámico soporte, donde dicha incorporación puede llevarse
a cabo en la cara superior o cara vista, en al menos uno de los
laterales o canto; y/o en la cara posterior del material cerámico
soporte. Es asimismo objeto de esta invención el uso de dicho
producto cerámico, en edificios de obra nueva, de rehabilitación o
de cualquier otra ubicación o localización.
Patent AU-2001253802-B2 (AU)
Title: Method for expansion of epithelial stem cells
Inventor: TSAI RAY JUI-FANG
IPC: C12N5/00
Filed: 2001-04-25
Granted: 2006-11-30
Abstract: Transplantation of epithelial stem cells, cultured ex vivo on specifically treated amniotic membrane, yields, with that amniotic membrane, a surgical graft having expanded epithelial stem cells. The method of creating this graft and the graft itself provide simple and effective means to reconstruct damaged tissue, a preferred example being corneal tissue. The source of the epithelial stem cells can be a very small explant from healthy autologous and allogeneic tissue biopsy. The amniotic membrane is treated such that its extracellular matrix is maintained, but its cells are killed.
Patent AU-2001257110-B2 (AU)
Title: Adhesive sheet and adhesion structure
Inventor: SAITOH TSUNEYOSHI
IPC: C09J7/29
Filed: 2001-04-18
Granted: 2005-09-22
Abstract: To provide an adhesive sheet which is provided with excellent stain resistance and is also provided with adhesion with another adhesive sheet. An adhesive sheet comprising a flexible substrate, an adhesive layer disposed on the back surface of said flexible substrate, and a protective layer disposed on the surface of said flexible substrate, characterized in that: said protective layer contains (1) a cured resin, and (2) a hydrophilizing agent of an inorganic oxide, an organosilicate compound or a mixture thereof; and that the thickness of said protective layer is from about 0.1 to about 60  mu m and the contact angle between the surface of said protective layer and water is from about 35 to about 65 degrees.
Patent AU-2001275881-B2 (AU)
Title: Ion channel assay methods
Inventor: MAHER MICHAEL P
IPC: G01N37/00
Filed: 2001-07-09
Granted: 2006-04-06
Abstract: A method of characterizing the biological activity of a candidate compound may include exposing cells to the candidate compound, and then exposing the cells to a repetitive application of electric fields so as to set the transmembrane potential to a level corresponding to a pre-selected voltage dependent state of a target ion channel.
Patent AU-2002231336-B2 (AU)
Title: Immunomodulatory polynucleotides and methods of using the same
Inventor: FEARON KAREN L
IPC: C12N15/00
Filed: 2001-12-27
Granted: 2007-06-28
Abstract: The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
Patent AU-2003202440-B2 (AU)
Title: Compositions and Methods for Genetic Modification of Plants
Inventor: TAGLIANI LAURA A
IPC: C12N15/29
Filed: 2003-03-24
Granted: 2006-04-27
Abstract: The invention provides DNA construct comprising in the 5' to 3' direction of transcription a promotor functional in a plant, an intron, a nucleotide sequence of interest, and a terminator region, said DNA construct comprising two non-identical recombination sites, where one of said non-identical recombination site is contained within said intron.
Patent AU-2003204645-B2 (AU)
Title: Method and apparatus for enhanced audio/video services with watermarks and associated data
Inventor: WONFOR PETER
IPC: H04L9/32
Filed: 2003-06-12
Granted: 2004-05-20
Abstract: A method and apparatus for controlled copying of a video or an audio signal transmitted over a cable television or direct satellite broadcast system, or the internet is described. Copyrighted video or audio material is protected from unwanted recording by the combination of a first watermark (W1) inserted into the video or audio signal by a content provider (10a) together with additional copy protection in the form of a second watermark (W2). The watermark or marks (W1, W2) are embedded in the active portion of the video or audio signal. Only if the consumer is willing to pay a fee is the video signal with the single watermark (V + W1) transmitted to the recording device (42a) which is then enabled to copy the video signal. However, where copying is permitted, the recording device is arranged to embed the second watermark (W2) into the video signal (V + W1 + W2) to be recorded onto a disc (46a) whereby further copying is prevented. This enables a single copy to be made upon payment. <IMAGE>
Patent AU-2003207298-B2 (AU)
Title: Nicotinamide derivates useful as p38 inhibitors
Inventor: ASTON NICOLA MARY
IPC: A61K/
Filed: 2003-02-10
Granted: 2009-09-03
Abstract: Compounds of formula (I):   
are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.
Patent AU-2003210670-B2 (AU)
Title: Compositions and methods for the detection, diagnosis and therapy of hematogolical malignancies
Inventor: CLAPPER JONATHAN DAVID
IPC: C12Q1/68
Filed: 2003-01-22
Granted: 2008-12-04
Abstract: Disclosed are methods and compositions for the detection, diagnosis, prognosis, and therapy of hematological malignancies, and in particular, B cell leukemias, lymphomas and multiple myelomas. Disclosed are compositions, methods and kits for eliciting immune and T cell responses to specific malignancy-related antigenic polypeptides and antigenic polypeptide fragments thereof in an animal. Also disclosed are compositions and methods for use in the identification of cells and biological samples containing one or more hematological malignancy-related compositions, and methods for the detection and diagnosis of such diseases and affected cell types. Also disclosed are diagnostic and therapeutic kits, as well as methods for the diagnosis, therapy and/or prevention of a variety of leukemias and lymphomas.
Patent AU-2003211616-B2 (AU)
Title: DNA and vector for regulating the expression of lachrymator synthase gene, method of regulating the expression of lachrymator synthase gene using the same, and plant with the regulated expression of lachrymator synthase gene
Inventor: TSUGE NOBUAKI
IPC: C12N9/90
Filed: 2003-02-28
Granted: 2008-07-24
Abstract: A DNA encoding a protein or polypeptide with an effect of converting 1-propenylsulfenic acid into a lachrymator, is new. Independent claims are also included for: (1) a primer for isolating the lachrymator synthase gene of a plant belonging to genus Allium, which contains a sequence of (XXV) comprising 26 base pairs; (2) isolating the Allium lachrymator synthase gene by using the primer; (3) a recombinant vector containing any of the DNAs; (4) a transformant containing the recombinant vector; (5) producing the protein or polypeptide with lachrymator synthase activity; (6) a protein or polypeptide with lachrymator synthase activity containing: (a) an amino acid sequence of (II), (VI), (VIII), (X), (XIV) or (XVI) comprising 164-169 amino acids; (b) an amino acid sequence based on the sequence of (II), (VI), (VIII), (X), (XIV) or (XVI) but with some amino acids added, deleted or substituted; or (c) an amino acid sequence comprising 65 % homology with the sequence of (II), (VI), (VIII), (X), (XIV) or (XVI); and (7) a nucleic acid molecule with a function of inhibiting the translation of mRNA concerning the protein or polypeptide. ACTIVITY : Ophthalmological. No biological data given. MECHANISM OF ACTION : None given.
Patent AU-2003301135-B2 (AU)
Title: Saposin C and receptors as targets for treatment of benign and malignant disorders
Inventor: SARTOR OLIVIER A
IPC: C07K14/415
Filed: 2003-12-18
Granted: 2008-06-19
Abstract: Saposin C was shown to be a trophic factor for a variety of cancer cells, e.g., prostate, lung, breast, and colon cancer cells. These cells expressed saposin C and responded to saposin C by increased levels of cell proliferation, cell migration, and cell invasion. Such activities typify and promote the neoplastic process. For prostate cancer, the androgen-insensitive prostate cancer cells responded to saposin C by higher levels of cell proliferation, cell migration and cell invasion than did the androgen-sensitive prostate cells. Stromal cells (from the prostate) were also responsive to saposin C-mediated signals in a manner typical of growth promoting compounds. The androgen-insensitive prostate cells were stimulated by saposin C to express higher levels of the urokinase plasminogen activator (uPA) and its receptor (uPAR), two proteins known to be involved in cell invasion. A conjugate of a peptide of the active region of saposin C (TX14A) and a toxin (saporin) was made and was shown to decrease the survival of prostate cancer cells, and the other cancer cells that were found to express saposin C (including cancers cells of the breast, colon, and lung). This conjugate or a compound of analogous action that inhibits cellular growth acting via a saposin-C binding receptor can be used to decrease tumor growth and/or treat disorders of stromal proliferation (e.g., benign prostatic hyperplasia, atherosclerosis, and vascular restenosis).
Patent AU-2003303722-B2 (AU)
Title: Operation of a forward link acknowledgement channel for the reverse link data
Inventor: GAAL PETER
IPC: H04L1/00
Filed: 2003-12-30
Granted: 2009-11-12
Abstract: An acknowledgement method in a wireless communication system. Initially, a reverse supplemental channel (R-SCH) frame is received at a base station. The base station then transmits an acknowledgement (ACK) signal if quality of the received R-SCH frame is indicated as being good. A negative acknowledgement (NAK) signal is transmitted only if the received data frame is indicated as being bad but has enough energy such that, if combined with energy from retransmission of the data frame, it would be sufficient to permit correct decoding of the data frame. If the best base station is known, the acknowledgement method may reverse the transmission of the acknowledgement signals for the best base station so that only NAK signal is sent. A positive acknowledgement is assumed in the absence of an acknowledgement. This is done to minimize the transmit power requirements. 
The ACK/NACK message is encoded with a block code and spreaded with a spreading code.
Patent AU-2004200638-B2 (AU)
Title: Methods and systems for language translation
Inventor: ZHOU MING
IPC: G06F40/00
Filed: 2004-02-18
Granted: 2010-09-16
Abstract: A translation service is disclosed, the service being provided to a wireless mobile device through a selective downloading of information from a server. The downloaded information includes a translation architecture having a language independent translation engine and at least one language dependent translation database. The language dependent translation database includes translation templates and a translation dictionary. A specialized database for a selected city or cities in the world can also be downloaded. Translation between languages is realized by applying the language dependent translation database, and optionally the city specific translation database, to the translation engine. The translation engine implements a user-driven term replacement scheme for simplifying the translation process. <IMAGE>
Patent AU-2004204387-B2 (AU)
Title: Helmet mounted electroluminescent position indicator
Inventor: SHERRING PAUL DAVID
IPC: A42B3/04
Filed: 2004-01-15
Granted: 2009-10-29
Abstract: A position indicator ( 10 ) for a helmet ( 1 ), for example a bicyclist's safety helmet, comprises a protruberant diffuser ( 12 ) containing one or more electroluminescent strips ( 60, 61 ); at least part of the emitted light is distributed through the diffuser ( 12 ), preferably by means of an internal convex reflector ( 62 ) which contains the power supply ( 70, 71, 72 ). A second strip is preferably arranged to be directly visible through a transparent window in the diffuser ( 12 ). The indicator is releasably attached to the helmet, for example by means of magnets ( 30 ), and may be arranged to detach in the event of an accident so as not to impair the normal function of the helmet. The diffuser preferably forms an illuminated band extending along the side of the helmet ( 1 ); the front ( 15 ) and rear ( 16 ) ends of the indicator may be distinguished from each other. A position indicator system comprises two indicators arranged symmetrically on either side of the helmet, so as to indicate the orientation of the wearer.
Patent AU-2004217906-B2 (AU)
Title: Thick shrink film having high oxygen transmission rate
Inventor: WILBURN DANIEL S
IPC: F16B4/00
Filed: 2004-03-05
Granted: 2009-01-08
Abstract: A multilayer film is relatively thick has an oxygen transmission rate of at least 10,000 cc/mil/24 hour@STP. The film is particularly suited for the packaging of fresh seafood. The film has a first layer which is an outer film layer which serves as a heat seal layer, and a second layer which serves as a high O<SUB>2</SUB>-transmission layer. The first layer has a thickness of from 2 to 20 percent of a total thickness of the multilayer film. The second layer comprises at least one member selected from the group consisting of: (i) ethylene/butyl acrylate copolymer, (ii) homogeneous ethylene/alpha-olefin copolymer having a density of from 0.86 to 0.91 g/cc; (iii) heterogeneous ethylene/alpha-olefin copolymer having a density of from 0.89 to 0.91 g/cc; (iv) ethylene/methyl acrylate copolymer having a methyl acrylate mer content of from 20 to 24 mole percent; (v) ethylene/vinyl acetate copolymer having a vinyl acetate mer content of from 10 to 30 mole percent; and (vi) styrene butadiene block copolymer. The at least one second layer having a thickness of from 80 to 98 percent of the total thickness of the multilayer film. The film is at least 1.5 mils thick. The invention also pertains to a bag made from the film, as well as a packaged product utilizing the film.
Patent AU-2004218180-B2 (AU)
Title: Novel aminopyridine derivatives as mGluR5 antagonists
Inventor: POUL EMMANUEL LE
IPC: A61P25/00
Filed: 2004-03-04
Granted: 2009-11-12
Abstract: The invention relates to novel aminopyridine derivatives of formula (I) wherein R1 is methyl an R 4  and amino group - NR 6 R 7  and R 5  forms an arylalkynyl- or heteroarylalkynyl-group. The compounds are useful in the prevention or treatment of central nervous system disorders as well as other disorders modulated by mGluR5 receptors.
Patent AU-2004245729-B2 (AU)
Title: System for temperature control within an automatic biological analyser
Inventor: BIANCALANI MAURIZIO
IPC: G01N21/76
Filed: 2004-05-19
Granted: 2009-09-17
Abstract: The present invention relates to a system for temperature control within an automatic biological analyzer, the automatic analyzer essentially comprising: support, guidance, and step-by-step transport means for reaction cuvettes on a path comprising a predetermined number of positions, a support turntable for analyte samples, a support turntable for reactants, means for taking defined quantities of samples and reactants and for injecting the same into the reaction cuvettes, means for washing the cuvettes, means for optical reading of the determination results and a computerized control system which permits carrying out pre-programmed analysis cycles. It consists in the fact that the temperature control system is connected to the lower part of the support turntable for the analyte samples, said system comprising within itself: at least one inlet air deflector, at least one outlet air deflector, a circular air transfer path positioned between the inlet deflector and the outlet deflector, and means for generating circulating air in the circular path, thereby permitting a reduction in the thermal variation between the inlet air and outlet air temperatures within the temperature control system. The invention finds a preferential application in the diagnostic field.
Patent AU-2005202951-B2 (AU)
Title: Gaming Machine With Multiple Master Controllers
Inventor: SHELLEY SCOTT
IPC: A63F13/02
Filed: 2005-07-05
Granted: 2012-04-26
Abstract: The present invention is directed to gaming and slot machine games and more particularly relates to a gaming machine which has two independent controllers in the one machine. More particularly, the present invention relates to a gaming machine having at least two controllers which are capable of running games in a master slave relationship or independently on one screen or independent games on separate screens in the same gaming machine cabinet. The invention further provides a gaming machine having at least two game controllers operating independently or in conjunction with each other increasing game options for a player but without increasing the cabinet volume or comprising space efficiency of existing machine cabinets. One particular advantage of the present invention is that a dual controller allows the possibility of a play of bonus or free games without "freezing" the primary game. Top Main Screen Screen Main Top Screen Backpla e/Motbr Board 9 Screen J/G 12 1/O 11 (switches, (switches, sound, lights, sound, lights, Inter Board prntr, coin etc) acceptor, note commns acceptor, hopper, etc) 13r Top Screen Power Main Processor Supply Screen -- 3 Board Processor - Board 6 -- 7
Patent AU-2005217103-B2 (AU)
Title: Sealing ring for a vehicle wheel
Inventor: KIDNEY DARREN
IPC: B60C15/028
Filed: 2005-01-12
Granted: 2012-02-09
Abstract: Disclosed is a sealing ring (8) for a vehicle wheel comprising a tubeless tire (1) with two tire beads that are embodied on the radially inward side thereof. The tubeless tire (1) is mounted on the radially outer side of a multipart rim (2) by means of the tire beads thereof. Said vehicle wheel further comprises a sealing ring (8) which seals the tire (1) radially inward towards the rim (2), is positioned on the radially outer side of the rim (2), extends in a peripheral direction along the circumference of the rim (2), and runs between the two tire (1) beads in an axial direction. The invention is characterized in that the sealing ring (8) is configured with a central ring member which is provided with a cylindrical inner surface that is to rest on the outer surface of rim while being embodied with one respective concentric flexible annular leg which is located on both axial sides of the central ring member and extends diagonally and radially outward in an axial direction from the central ring member. Moreover, deformable sealing elements which extend along the circumference of the annular leg on the radially inward-facing surface thereof are configured on the end of the leg that faces away from the central ring member.
Patent AU-2005315913-B2 (AU)
Title: Tetracyclic imidazo-benzodiazepines as GABA receptors modulators
Inventor: HENNER KNUST
IPC: A61K31/5517
Filed: 2005-12-05
Granted: 2011-11-24
Abstract: The present invention is concerned with substituted imidazo [1,5-a] [1,2,4] triazolo [1,5-d] [1,4]benzodiazepine derivatives of the following formula (I) wherein R' is hydrogen, halogen, lower alkyl, lower alkyl substituted by halogen, lower alkoxy, lower alkoxy substituted by halogen, nitro, cycloalkyl, -O(CH)O(CH)OH or -C≡C-R'; R is hydrogen or methyl; R is lower alkyl, lower alkyl substituted by halogen, lower alkenyl, lower alkenyl substituted by halogen, lower alkynyl, -(CH)-cycloalkyl, -(CR'R")CH, or is phenyl, unsubstituted or substituted by halogen, or is pyridinyl or thienyl, unsubstituted or substituted by lower alkyl, or is -(CH)-NH-cycloalkyl, lower alkenyl-cycloalkyl, lower alkynyl-(CR'R")OH, or is lower alkynyl-phenyl, wherein the phenyl ring is unsubstituited or substituted by halogen, CF, lower alkyl or lower alkoxy; R' is hydrogen or lower alkyl; R" is hydrogen, hydroxy or lower alkyl; n is 0, 1 or 2; m is 1, 2 or 3; o is 1 or 2; and with their pharmaceutically acceptable acid addition salts. It has been found that this class of compounds show high affinity and selectivity for GABA A α 5 receptor binding sites and might be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease.